About 100 reports

  • Rheumatoid Arthritis Classification Criteria
  • 3.1 RHEUMATOID ARTHRITIS TESTING OVERVIEW
  • Arthritis
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlobalData's company
  • Arthritis Treatment Drugs Markets in China
  • IV. ARTHRITIS TREATMENT DRUGS PRODUCTION AND
  • Arthritis
  • China
  • Demand
  • Novartis AG
  • Pfizer Inc.
  • IV. ARTHRITIS TREATMENT DRUGS PRODUCTION AND
  • Arthritis Treatment Drugs Imports and Exports
  • Arthritis
  • China
  • Demand
  • Trade
  • Roche Pharmaceutical Co., Ltd

Rheumatoid arthritis

4546 5000 3864
  • Marketed Drugs: Rheumatoid Arthritis
  • Treatment: Rheumatoid Arthritis
  • Arthritis
  • Europe
  • Japan
  • Pfizer Inc.
  • Roche Group

Key Features of the Report: - Rheumatoid Arthritis Patient Flow - Rheumatoid Arthritis Prevalence - Rheumatoid Arthritis Diagnosed Patients - Rheumatoid Arthritis Treated Patients

  • Arthritis
  • Europe
  • France
  • World
  • Forecast
  • Arthritis Treatment Drugs Companies in China
  • Arthritis Treatment Drugs Sales Volume
  • Arthritis
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.

There is no cure for rheumatoid arthritis.

  • Anti Rheumatic
  • Arthritis
  • Therapy
  • United States
  • World

Antirheumatoids: Call of Rheumatoid Arthritis ##. ## Prologue towards Rheumatoid Arthritis ##. ## Obtainable Treatment for Rheumatoid Arthritis ##.

  • Anti Rheumatic
  • Arthritis
  • Chronic Disease
  • Therapy
  • World

Rheumatoid Arthritis Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Rheumatoid Arthritis pipeline products, Rheumatoid

  • Arthritis
  • France
  • Germany
  • Italy
  • Market Size

Global Rheumatoid Arthritis Market DataPack (2016-2020) Types of Arthritis Global Rheumatoid Arthritis Market by Value (2015-2020E) Global Rheumatoid Arthritis Market by Drug Class (2015/ 2020E) Global Rheumatoid Arthritis Market Share by Drug (2016E)

  • Arthritis
  • Chronic Disease
  • Pathology
  • World
  • 3.1 BIBLIOGRAPHY
  • ACR DIAGNOSTIC CRITERIA FOR RA
  • Arthritis
  • Australia
  • Japan
  • United States
  • Forecast

Key Features of the Report: - Rheumatoid Arthritis Patient Flow - Rheumatoid Arthritis Prevalence - Rheumatoid Arthritis Diagnosed Patients - Rheumatoid Arthritis Treated Patients

  • Arthritis
  • Europe
  • France
  • Germany
  • Forecast

Rheumatoid Arthritis Diagnostic Tests Market Taxonomy ##. ##.

  • Arthritis
  • Chronic Disease
  • Pathology
  • World
  • Forecast

Gouty Arthritis (Gout) - Epidemiology Forecast to 2027 ##.

  • Arthritis
  • France
  • Germany
  • Italy
  • Spain

Rheumatoid Arthritis (RA) -Epidemiology Forecast to 2027 ##.

  • Arthritis
  • France
  • Germany
  • Italy
  • Spain

Juvenile Rheumatoid Arthritis - Epidemiology Forecast to 2027 ##.

  • Arthritis
  • France
  • Germany
  • Italy
  • Spain

Rheumatoid Arthritis Testing - Europe Analysis and Market Forecasts ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Executive Summary ##. ## Key Metrics in Major Markets ##. ## Market Dynamics ##. ## Key Players in the Rheumatoid Arthritis Testing Market ##. ## Rheumatoid

  • Arthritis
  • Europe
  • Forecast
  • TOP-LINE PREVALENCE FOR RHEUMATOID ARTHRITIS
  • ACR Classification of functional capacity in rheumatoid arthritis
  • Arthritis
  • Chronic Disease
  • Pathology
  • Europe

Arthritis Testing Market, 2016 Table ##: APAC RF Test Volume Forecast (thousands) by Country, 2013-2022 Table ##: APAC Anti-CCP Antibody Test Volume Forecast (thousands) by Country, 2013-2022 Table ##: APAC CRP Test Volume Forecast (thousands) by Country, 2013-2022 Table ##: APAC Rheumatoid

  • Arthritis
  • Forecast

Rheumatoid Arthritis Testing - North America Analysis and Market Forecasts ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Executive Summary ##. ## Key Metrics in Major Markets ##. ## Market Dynamics ##. ## Key Players in the Rheumatoid Arthritis Testing Market ##. ## Rheumatoid

  • Arthritis
  • North America
  • Forecast

Rheumatoid Arthritis (RA) : ##MM Market Analysis ##. ##. ##MM Market Size of Rheumatoid Arthritis (RA) ##. ##. ##MM Percentage Share of drugs marketed for Rheumatoid Arthritis (RA) ##. ##. ##MM Market Sales of Rheumatoid Arthritis (RA) by Products ##.

  • Arthritis
  • Chronic Disease

Gouty Arthritis (Gout) : ##MM Market Analysis ##. ##. ##MM Market Size of Gouty Arthritis (Gout) ##. ##. ##MM Percentage Share of drugs marketed for Gouty Arthritis (Gout) ##. ##. ##MM Market Sales of Gouty Arthritis (Gout) by Products ##.

  • Arthritis
  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology

Juvenile Rheumatoid Arthritis : ##MM Market Analysis ##. ##. ##MM Market Size of Juvenile Rheumatoid Arthritis ##. ##. ##MM Percentage Share of drugs marketed for Juvenile Rheumatoid Arthritis ##. ##. ##MM Market Sales of Juvenile Rheumatoid Arthritis by Products ##.

  • Arthritis
  • Chronic Disease

Rheumatoid Arthritis Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Rheumatoid Arthritis pipeline products, Rheumatoid

  • Arthritis
  • Europe
  • France
  • Germany
  • Market Size

Japan Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Rheumatoid Arthritis Treatments ##) Rheumatoid Arthritis Pipeline ##) Japan Rheumatoid Arthritis Epidemiology ##) Marketed

  • Arthritis
  • Chronic Disease
  • Pathology
  • Japan
  • Market Size

Germany Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Rheumatoid Arthritis Treatments ##) Rheumatoid Arthritis Pipeline ##) Germany Rheumatoid Arthritis Epidemiology ##) Mark

  • Arthritis
  • Chronic Disease
  • Pathology
  • Germany
  • Market Size

Italy Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Rheumatoid Arthritis Treatments ##) Rheumatoid Arthritis Pipeline ##) Italy Rheumatoid Arthritis Epidemiology ##) Marketed

  • Arthritis
  • Chronic Disease
  • Pathology
  • Italy
  • Market Size

France Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Rheumatoid Arthritis Treatments ##) Rheumatoid Arthritis Pipeline ##) France Rheumatoid Arthritis Epidemiology ##) Market

  • Arthritis
  • Chronic Disease
  • Pathology
  • France
  • Market Size

UK Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Rheumatoid Arthritis Treatments ##) Rheumatoid Arthritis Pipeline ##) UK Rheumatoid Arthritis Epidemiology ##) Marketed Drugs

  • Arthritis
  • Chronic Disease
  • Pathology
  • United Kingdom
  • Market Size

Spain Rheumatoid Arthritis Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Rheumatoid Arthritis Treatments ##) Rheumatoid Arthritis Pipeline ##) Spain Rheumatoid Arthritis Epidemiology ##) Marketed

  • Arthritis
  • Chronic Disease
  • Pathology
  • Spain
  • Market Size